Insulin Resistance Is Better Estimated by Using Fasting Glucose, Lipid Profile, and Body Fat Percent Than by HOMA-IR in Japanese Patients with Type 2 Diabetes and Impaired Glucose Tolerance: An Exploratory Study

被引:2
|
作者
Nakamura, Yui [1 ]
Otaki, Soichiro [1 ]
Tanaka, Yohei [1 ]
Adachi, Ayaka [1 ]
Wada, Nobuhiko [1 ]
Tajiri, Yuji [1 ,2 ]
机构
[1] Kurume Univ, Med Ctr, Diabet Ctr, Kurume, Japan
[2] Kurume Univ, Diabet Ctr, Med Ctr, Kurume 8390863, Japan
关键词
insulin resistance; steady state plasma glucose; glucose clearance; metabolic factor; anthropometric factor; HOMEOSTASIS MODEL ASSESSMENT; SENSITIVITY; INDEX; TRIGLYCERIDES; SECRETION; ACID;
D O I
10.1089/met.2023.0181
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aims: The aim of the present study is to estimate insulin resistance (IR) using clinically available parameters except for serum insulin or C-peptide concentration to overcome the limitation of homeostasis model assessment of IR (HOMA-IR), which has been widely used in clinical practice.Patients and Methods: Fifty-two admitted patients with type 2 diabetes or impaired glucose tolerance were enrolled, and steady state plasma glucose (SSPG) method and cookie meal tolerance test were performed together with fasting blood sampling and anthropometric measurements. Insulin sensitivity measured by SSPG was estimated as glucose clearance corrected by the excretion of glucose into urine (C-GC).Results: Log-transformed (C-GC) was negatively correlated with fasting plasma glucose (FPG), log (Fasting triglyceride: TG), log (Fasting TG/Fasting high-density lipoprotein cholesterol: HDLC), and their area under the curves (AUCs). Fasting and AUC-HDLC was positively and fasting free fatty acid (FFA) was negatively correlated with log (C-GC). Body fat (%) was negatively correlated with log (C-GC). Multiple regression analysis on log (C-GC) as an outcome variable revealed that FPG, log (AUC-TG/AUC-HDLC), body fat (%), and fasting FFA were selected as significant predictive variables and contributed to log (C-GC) by 60% (adjusted R2). Replacing log (AUC-TG/AUC-HDLC) with its fasting value, log (Fasting TG/Fasting HDLC), this model still showed a strong contribution to log (C-GC) by 57% (adjusted R2). These contributions were stronger than those in log (HOMA-IR) (52.5%), log (Fasting C-peptide) (45.7%) to log (C-GC).Conclusions: It is plausible that our estimation for IR without the inclusion of plasma insulin concentration can be applied in Japanese patients whose HOMA-IR is not appropriately available. The model using fasting values is less complicated and could be the best way for the estimation of IR.
引用
收藏
页码:199 / 206
页数:8
相关论文
共 50 条
  • [1] HOMA-IR Assessment for Impaired Glucose Tolerance, Impaired Fasting Glucose and Insulin Resistance Diagnosis
    Severeyn, Erika
    Velasquez, Jesus
    Perpinan, Gilberto
    Herrera, Hector
    Wong, Sara
    Diaz, Jose
    Altuve, Miguel
    VIII LATIN AMERICAN CONFERENCE ON BIOMEDICAL ENGINEERING AND XLII NATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING, 2020, 75 : 1275 - 1283
  • [2] Size and shape of the associations of glucose, HbA1c, insulin and HOMA-IR with incident type 2 diabetes: the Hoorn Study
    Ruijgrok, Carolien
    Dekker, Jacqueline M.
    Beulens, Joline W.
    Brouwer, Ingeborg A.
    Coupe, Veerle M. H.
    Heymans, Martijn W.
    Sijtsma, Femke P. C.
    Mela, David J.
    Zock, Peter L.
    Olthof, Margreet R.
    Alssema, Marjan
    DIABETOLOGIA, 2018, 61 (01) : 93 - 100
  • [3] Increase in Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) Had a Strong Impact on the Development of Type 2 Diabetes in Japanese Individuals with Impaired Insulin Secretion: The Saku Study
    Morimoto, Akiko
    Tatsumi, Yukako
    Soyano, Fumie
    Miyamatsu, Naomi
    Sonoda, Nao
    Godai, Kayo
    Ohno, Yuko
    Noda, Mitsuhiko
    Deura, Kijyo
    PLOS ONE, 2014, 9 (08):
  • [4] The natural logarithm of zinc-α2-glycoprotein/HOMA-IR is a better predictor of insulin sensitivity than the product of triglycerides and glucose and the other lipid ratios
    Qu, Chunmei
    Zhou, Xiaoxin
    Yang, Gangyi
    Li, Ling
    Liu, Hua
    Liang, Zerong
    CYTOKINE, 2016, 79 : 96 - 102
  • [5] Size and shape of the associations of glucose, HbA1c, insulin and HOMA-IR with incident type 2 diabetes: the Hoorn Study
    Carolien Ruijgrok
    Jacqueline M. Dekker
    Joline W. Beulens
    Ingeborg A. Brouwer
    Veerle M. H. Coupé
    Martijn W. Heymans
    Femke P. C. Sijtsma
    David J. Mela
    Peter L. Zock
    Margreet R. Olthof
    Marjan Alssema
    Diabetologia, 2018, 61 : 93 - 100
  • [6] A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes
    Marbury, T. C.
    Schwartz, S.
    Rosenberg, M. A.
    Jarlwala, N.
    Becker, R. H. A.
    Johnston, P. S.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2008, 116 (05) : 282 - 288
  • [7] Thiazolidinedione therapy in the prevention/delay of Type 2 diabetes in patients with insulin resistance and impaired glucose tolerance
    Durbin, RJ
    DIABETOLOGIA, 2002, 45 : A105 - A105
  • [8] Thiazolidinedione therapy in the prevention/delay of type 2 diabetes in patients with impaired glucose tolerance and insulin resistance
    Durbin, RJ
    DIABETES OBESITY & METABOLISM, 2004, 6 (04): : 280 - 285
  • [9] Adipose Tissue Insulin Resistance in Overweight and Lean Patients with Impaired Glucose Tolerance or Type 2 Diabetes
    Miya, Aika
    Nakamura, Akinobu
    Kameda, Hiraku
    Cho, Kyuyong
    Miyoshi, Hideaki
    Atsumi, Tatsuya
    DIABETES, 2019, 68
  • [10] Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness - The insulin resistance atherosclerosis study
    Wagenknecht, LE
    D'Agostino, RB
    Haffner, SM
    Savage, PJ
    Rewers, M
    DIABETES CARE, 1998, 21 (11) : 1812 - 1818